What's New with Hypertension: How Low to Go, New Evidence, Consensus Recommendations, and Treating Resistant Hypertension is organized by University Learning Systems (ULS) and will be held from Jan 27, 2018 - Jan 27, 2021. This Conference has been approved for a maximum of 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
• Canadian Physicians
• Physician Assistants
• Nurse Practitioners
This course provides five (5) hours of AMA Category 2 credit.
American Osteopathic Association (AOA): This course provides five (5) hours of AMA Category 2 credit.
Members of the College of Family Physicians of Canada CFPC : This course provides five (5) hours of AMA Category 2 credit.
American Academy of Physician Assistants (AAPA): This course provides five (5) hours of AMA Category 2 credit.
At the conclusion of this session, the participant will be able to:
• Review medications and lifestyle modifications that are recommended for the treatment of hypertension.
• Compare and contrast guidelines and consensus recommendations for the treatment of patients with hypertension.
• Identify patient specific blood pressure goals for patients with hypertension.
• Interpret findings from the SPRINT trial and identify strengths and weaknesses of these data when applies to determining a patient-specific BP goal.
• Identify appropriate and patient specific antihypertensive agents for the treatment of hypertension based on age, gender, and comorbid diseases.
• Describe recommended drug therapy for patients with hypertension with and without compelling indications.
• Recommend appropriate combination drug therapy for the treatment of hypertension.
• Describe risks of certain combination antihypertensive drug therapies.
• Define resistant hypertension and recommend appropriate treatment options.
• Design patient-centered antihypertensive treatment plans in complex patients with hypertension.
Additional details will be posted as soon as they are available.
Renal Medicine Disease and Hypertension